Effects of anti-Fas antibodies on lymphocytes and other organs: Preparation of original and new monoclonal antibodies and amelioration of systemic autoimmune disease

International Reviews of Immunology

Volumn 18, Issue 4, 1999, Pages 329-345

  Yonehara, Shin ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Arteritis; Arthritis; Autoimmune disease; Fas; gld; Glomerular nephritis; lpr and mAb

Indexed keywords

EID: 0032812798     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189909088487     Document Type: Article

References (44)

1. S. Yonehara, A. Ishii and M, Yonehara. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 747-1756, 1989.
2. N. Itoh, S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto and S. Nagata. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243, 1991.
3. B.C. Trauth, C. Klas, A.M.J. Peters, S. Matzku, P. Moller, W. Falk, K.-M. Debatin and P.H. Krammer. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305, 1989.
4. A. Öehm, I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, W.M. Li, S. Richards, J. Dhein, B.C. Trauth, H. Ponsting and P.H, Krammer. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor receptor superfamily: Sequence identity with the Fas antigen. J. Biol. Chem. 267, 10709-10715, 1992.
5. T. Suda, T. Takahashi, P. Golstein and S. Nagata. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993.
6. R. Watanabe-Fukunaga, C.I. Brannan, N.G. Copeland, N.A. Jenkins and S. Nagata. Lymphoproliferation disorder in mice explained by defects in Fas that mediates apoptosis. Nature 356: 314-317, 1992.
7. T. Takahashi, M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda and S. Nagata. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76: 969-976, 1994.
8. B.S. Andrews, R.A. Eisenberg, A.N. Theofilopoulos, S. Izui, C.B. Wilson, P.J. McConah, E.D. Murphy, J.B. Roths and F.J. Dixon. Spontaneous murine lupus-like syndromes. Clinical and immunopathologic manifestations in several strains. J. Exp. Med. 148: 1198-1215, 1978.
9. P.L. Cohen and R.A. Eisenberg. Lpr and gld. Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269, 1991.
10. E.D. Murphy and J.B. Roths. Autoimmunity and lymphoproliferation. Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In Genetic Control of Autoimmune Disease, N.R Rose, P.E. Bigazzi and N.L. Werner (eds.), Elsevier North Holland Inc., NY, pp. 207-221, 1979.
11. M. Nose, M. Nishimura and M. Kyogoku. Analysis of granulomatous arthritis in MRL Mp autoimmune disease mice bearing lymphoproliferative genes. Am. J. Pathol. 135: 271-280, 1989
12. K. Matsumoto, Y. Yoshikai, T. Asano, K. Himeno, A. Iwasaki and K. Nomoto. Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J. Exp. Med. 173: 127-132, 1991.
13. T. Zhou, H. Bluethmann, J. Eldridge, M. Brockhaus, K. Berry and J.D. Mountz. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J. Immunol. 147. 466, 1991.
14. Y. Taniguchi, M.R. Ito, S. Yonehara and M. Nose. Role of macrophages in the development of arteritis in MRL strains of mice with a deficit in Fas-mediated apoptosis. Clin. Exp. Immunol. 106: 26-34, 1996.
15. J.H. Russell, B. Rush, C. Weaver and R. Wang. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90: 4409-4413, 1993.
16. G.G. Singer and A.K. Abbas. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1: 365-371, 1994.
17. S. Hanabuchi, M, Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita and K. Okumura, Fas and its ligand in general mechanism of T-cell-mediated cytotoxicity Proc. Natl. Acad. Sci. USA 91: 4930-4934, 1994.
18. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177: 195-200, 1993.
19. S. Nagata. Apoptosis by death factor. Cell 88: 355-365, 1997.
20. C. Giordano, G. S tasse, R. De Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi and A. Galluzzo. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275: 960-963, 1997.
21. A. Nishio, T. Katakai, C. Oshima, S, Kasakura, M. Sakai, S. Yonehara, T. Suda, S. Nagata and T. Masuda. A possible involvement of Fas-Fas ligand signaling in the pathogenesis of murine autoimmune gastritis. Gastroenterology 111: 959-967, 1996.
22. A.V. Chervonsky, Y. Wang, F.S. Wong, I. Visintin, R.A. Flavell and L.A. Matis. The role of Fas in autoimmune diabetes. Cell 89: 17-24, 1997.
23. K.A. Sabelko, K.A. Kelly, M.H. Nahm, A.H. Cross and J.H. Russell. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159: 3096-3099, 1997.
24. J. Ogasawara, F.R. Watanabe, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda and S. Nagata. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809, 1993.
25. Y. Nishimura, A. Ishii, Y. Kobayashi, Y. Yamasaki and S. Yonehara. Expression and function of mouse Fas on immature and mature T cells. J. Immunol. 154: 4395-4403, 1995.
26. Y. Nishimura, Y. Hirabayashi, Y. Matsuzaki, P. Musette, A Ishii, H. Nakauchi, T. Inoue and S. Yonehara. In vivo analysis of Fas antigen-mediated apoptosis, Effects of agonistic anti-mouse Fas monoclonal antibody on thymus, spleen and liver. Int. Immunol. 9: 307-316, 1997.
27. Y. Nishimura-Morita, M. Nose, T. Inoue and S. Yonehara. Amelioration of systemic autoimmune disease by the stimulation of apoptosis-promoting receptor Fas with anti-Fas mAb. Int. Immunol. 9: 1793-1799, 1997.
28. M. Tanaka, T. Suda, T. Yatomi, N. Nakamura and S. Nagata. Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes. J. Immunol. 158: 2303-2309, 1997.
29. M.P. Boldin, E.E. Varfolomeev, Z. Pancer, I.L. Mett, J H. Camonis and D. Wallach. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798, 1995.
30. A M. Chinnaiyan, K. O'Rourke, M. Tewari and V.M. Dixit. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512, 1995.
31. X. Yang, R. Khosravi-Far, H.Y. Chang and D, Baltimore. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89: 1067-1076, 1997.
32. J. Dhein, H. Walczak, C. Baumler, K.-M. Debatin and P.H. Krammer. Autocrine T-cell suicide mediated by APO-1/(Fas CD95). Nature 373: 438-441, 1995.
33. T. Brunner, R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Force, W.R. Force, D.H. Lynch, C.F. Ware and D.R. Green. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas Nature 373. 441-444, 1995.
34. S.-T. Ju, D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger and A. Marshak-Rothstein. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448, 1995.
35. C. Klas, K.-M. Debatin, R.R. Jonker and P.H. Krammer. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5. 625-630, 1993.
36. Y. Nishimura, A. Ishii and S. Yonehara. Expression and function of apoptosis antigen Fas on T lymphocytes in periphery and thymus. In Leukocyte Typing V. White Cell Differentiation Antigen. S.F. Schlossman et al. (eds.). Oxford University Press, Oxford, pp. 1144-1148, 1995.
37. G.S. Firestein, M. Yeo and N.J. Zvaifler. Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 96: 1631-1638, 1995.
38. T. Nakajima, H. Aono, T. Hasunuma, K. Yamamoto, T. Shirai, K. Hirohata and K. Nishioka. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 38: 485-491, 1995.
39. K. Fujisawa, H. Asahara, K. Okamoto, H. Aono, T. Hasunuma, T. Kobata, Y. Iwakura, S. Yonehara, T. Sumida and K. Nishioka. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J. Clin. Invest. 98: 271-278, 1996.
40. + T cells. Nature 376: 181-184, 1995.
41. K. Nakanishi, K. Matsui, S. Kashiwamura, Y. Nishioka, J. Nomura, Y. Nishimura, N. Sakaguchi, S. Yonehara, K. Higashino and S. Shinka. IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation. Int. Immunol. 8: 791-798, 1996.
42. M.A. Maldonado, R.A. Eisenberg, E. Roper, P.L. Cohen and B.L. Kotzin. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181: 641-648, 1995.
43. - T cells but normal autoantibody production in Ipr/Ipr mice lacking major histocompatibility complex class I molecules. Eur. J. Immunol. 25: 37-41, 1995.
44. B A. Jacobson, D J. Panka, K.-M. Nguyen, J. Erikson, A.K. Abbas and A. Marshak-Rothstein. Anatomy of autoantibody production. Dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3: 509-519, 1995.